CC
LUCD icon

Centiva Capital’s Lucid Diagnostics LUCD Stock Holding History

Centiva Capital’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Buy
109,440
+40,377
+58% +$43.5K ﹤0.01% 1501
2026
Q1 		$79.4K Buy
+69,063
New +$87.9K ﹤0.01% 1428
2025
Q4 		– Sell
-24,949
Closed -$25.2K – 1470
2025
Q3 		$25.2K Buy
+24,949
New +$27.2K ﹤0.01% 978

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Centiva Capital's LUCD Position: Q2 2026 in Review

Centiva Capital increased its Lucid Diagnostics (LUCD) stake by 58% in Q2 2026, buying an estimated $43.5K and bringing the position to 109,440 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

Centiva Capital first reported a position in LUCD in Q3 2025 and has held it in 3 quarters since. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Centiva Capital held 109,440 shares of Lucid Diagnostics worth $117K as of Q2 2026.
  • Centiva Capital bought 40,377 Lucid Diagnostics shares in Q2 2026, an estimated $43.5K.
  • Lucid Diagnostics made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1501 holding.
  • Centiva Capital first reported a position in Lucid Diagnostics in Q3 2025 and has held it in 3 quarters since.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.